Trial NCT01920477

View at ClinicalTrials.gov 
Org. Study IDs: 116910

Last trial update was posted on 2019-06-06

MeSH Interventions

Ofatumumab

MeSH Conditions

Pemphigus

Other Conditions

Pemphigus Vulgaris

Stopping Reasons

Novartis has acquired the rights to ofatumumab and terminated the OPV116910 and OPV117059 studies. This decision is not linked to any safety consideration.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID